[DIV28ANNOUNCE] Division 28 July 2019 newsletter

Good afternoon APA Division 28,


Attached is the July issue of the division newsletter. I’m also attaching the PDF of Division 28 programming for the upcoming convention. Please enjoy!



Erin McClure 



Erin A. McClure, Ph.D.
Assistant Professor
Addiction Sciences Division
Medical University of South Carolina
67 President St., MSC 861
Charleston, SC 29425
Phone: 843-792-7192


Like us on Facebook!  



[#DIV28SUPER] 2019 Annual Vermont Center on Behavior & Health National Conference


7th Vermont Center on Behavior and Health Annual Conference
October 10-11, 2019
Burlington Hilton Hotel, Burlington, Vermont

The 7th Annual VCBH Conference will focus on the intersection between tobacco regulatory science and tobacco control, two of the major fields in tobacco research. We will bring together renowned researchers in both fields to see how each may compliment one another to decrease tobacco use nationwide.


This year's keynote speaker is Dorothy Hatsukami, Ph.D., Forster Family Chair in Cancer Prevention at the Masonic Cancer Center and Professor of Psychiatry at the University of Minnesota. Dr. Hatsukami's areas of expertise include nicotine addiction and its treatment, including testing medications such as nicotine vaccine and combination medications, in smokers.


We are also announcing the call for poster abstracts focused on research related to tobacco regulatory science or tobacco control. Abstracts will be evaluated on the basis of scientific merit. Please send submissions (including title, authors, affiliations, and 250-word abstract) to Diann Gaalema at diann.gaalema@med.uvm.edu by August 15. 
For conference program, registration and hotel links, please visit our conference webpage.
Can't attend the conference? Watch it LIVE at: https://livestream.com/VCBH/Conference2019 


[#DIV28SUPER] Submit Behavioral and Social Sciences Accomplishments by July 31, 2019 – Help the NIH Generate a Comprehensive List!

The NIH Office of Behavioral and Social Sciences Research (OBSSR) is seeking comment and input from the research and health/public health communities to help inform a list of impactful public health and healthcare accomplishments/contributions resulting from behavioral and social sciences research (BSSR). Follow this link to view how NIH defines BSSR. Note: This BSSR accomplishments list will be broad and will not be limited to NIH-funded research.

On Monday, April 22, OBSSR launched its IdeaScale website, a public comment platform, to engage the research community-at-large for the development of a broad accomplishments list. Your feedback will be used to make the list of accomplishments as meaningful as possible and to communicate the significance of BSSR.

OBSSR is using IdeaScale to make it easy to submit to this list of accomplishments. (Once an IdeaScale account is created, a user can submit comments, browse and respond to comments that have already been submitted, and vote for their favorites.) OBSSR wants your input!


Please forward this information to your colleagues or other contacts who may be able to provide feedback and inform this list of BSSR accomplishments.

The deadline to participate in this BSSR accomplishments crowdsource is Wednesday, July 31, 2019 at midnight ET.

For inquiries or more information, contact: OBSSRnews@mail.nih.gov.



Many thanks,

Erica Moore

Communications Director

Office of Behavioral and Social Sciences Research

National Institutes of Health

P: 301-594-4392

E: erica.moore2@nih.gov


Patricia Clem Kobor | Sr. Science Policy Analyst

Government Relations | (202) 336-5933| pkobor@apa.org

American Psychological Association: www.apaservices.org

Twitter: @APA, @APAScience

Advancing psychology to benefit society and improve people's lives





[#DIV28SUPER] American Psychological Association Prize for Interdisciplinary Team Research

Dear all,

As you plan your APA convention attendance, please note the following session, which is based on the fact that the Center for Study of Tobacco Products at VCU won the American Psychological Association Prize for Interdisciplinary Team Research. Congratulations to Dr. Eissenberg and team!

"Interdisciplinary Science and Tobacco Product Regulation—Informing the FDA About Electronic Cigarettes", Sunday August 11, 10:00 am-11:50 am in room W187a, Level 1-West Building of the McCormick Place Convention Center.

Matthew W. Johnson, Ph.D.
Google Scholar: https://scholar.google.com/citations?user=fWhYUvwAAAAJ&hl=en
Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD  21224-6823
Tel: 410-550-0056
Fax: 410-550-0030
Email: mwj@jhu.edu

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Division 28 Program Highlights - APA 2019 Convention

Hello all, 

Please see attached for our exciting Division 28 program highlights for the 2019 APA convention in Chicago (August 8-11). Please feel free to distribute far and wide. 

And just a reminder that additional details on the full APA program can be found at the APA website (https://convention.apa.org/), as well as information on downloading the mobile app for easy viewing and schedule planning.  

We hope to see you all there! 



Meredith S. Berry, Ph.D.
Assistant Professor
Department of Health Education and Behavior
Department of Psychology
University of Florida
2019 Program Chair -- Division 28 Psychopharmacology and Substance Abuse​
Gainesville, Florida 32611
Email: mberry@ufl.edu


[#DIV28SUPER] Division 28 Survey Invitation

Dear Division 28 members. Please see the following survey invitation by Division members Bill Stoops and Justin Strickland.  Best, Matt



You are being invited to take part in a research study on feelings about clinical research participation. The entire study will take place using a web-based survey where you will be asked to answer questions about hypothetical research scenarios, attitudes, and behaviors. Note that you do not have to conduct clinical or human research yourself to participate and the survey is open to anyone willing to participate that is 18 years of age or older.

The survey will take approximately 10 minutes to complete. If you complete the survey, you will be entered to win one of fifty $20 Amazon gift cards. This gift card will be sent to you via an email entered in a survey separate from the survey containing your responses.

The survey is located in the link below as is a cover letter providing more details about the study. We hope that you will find the time to complete this brief survey.


This project has been approved by the University of Kentucky Institutional Review Board (IRB). If you have questions about the study contact the Principal  Investigator William W. Stoops, Ph.D. at 859-257-5388 or at William.stoops@uky.edu or the Study Coordinator Justin C. Strickland, Ph.D. at Justrickland@uky.edu. Thank you in advance for your assistance with this important project.


William W. Stoops, Ph.D. and Justin C. Strickland, Ph.D.

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28


[#DIV28SUPER] Call for Papers: Experimental and Clinical Psychopharmacology

Special Issue for April 2020 on:

Advancing the Translation Between Clinical and Preclinical Models of Individual Differences in Vulnerability in Substance Use Disorders

This special issue will provide an overview of current translational research from both human and nonhuman animal researchers investigating individual difference factors in vulnerability to drug and alcohol use disorders. The goal of this special issue is to highlight translational clinical and preclinical research and to catalyze future translational approaches in the field. We encourage submission of review articles and original research reports in these areas, including individual difference factors in environmental, trait, and/or genetic domains. We encourage research that is translational in nature and would be especially interested in paired-research articles from different laboratories that are investigating the same individual difference factors across clinical and preclinical models. If submitting paired articles, authors are also invited to submit a comment on that set of articles. Nonhuman animal research that is translatable to the human conditions and human research that can be back translated to a nonhuman model are preferred. Papers addressing a variety of substances, including alcohol, marijuana, stimulants, and opiates, and their disorders, are welcome.

Researchers in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (http://pha.edmgr.com/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue on Advancing the Translation Between Clinical and Preclinical Models of Individual Differences in Vulnerability to Substance Use Disorders.  All submissions will undergo our normal peer review. Manuscripts received no later than October 1, 2019 will be considered for inclusion in the special issue. We strongly encourage individuals to contact the guest editors in advance with their ideas and a draft of the title and abstract.

Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, Melissa A. Cyders, PhD, at mcyders@iu.edu or Dustin J. Stairs, PhD, at dustinstairs@creighton.edu, or the Editor, William W. Stoops, PhD at william.stoops@uky.edu.

William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science

Interim Director
Clinical Research Support Office

The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.